MWNA
DTIL icon

Marshall Wace North America’s Precision BioSciences DTIL Stock Holding History

Marshall Wace North America’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-146
Closed -$61K – 1315
2019
Q4 		$61K Buy
146
+106
+265% +$33.3K ﹤0.01% 1130
2019
Q3 		$10K Sell
40
-896
-96% -$292K ﹤0.01% 1259
2019
Q2 		$372K Sell
936
-808
-46% -$325K ﹤0.01% 939
2019
Q1 		$939K Buy
+1,744
New +$926K 0.01% 681

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
ACWM
Adams Chetwood Wealth Management Durham, North Carolina $176M AUM 8.48% 1-Year Est. Return

Marshall Wace North America's DTIL Position: Q1 2020 in Review

Marshall Wace North America sold out of Precision BioSciences (DTIL) in Q1 2020, closing a stake of 146 shares — an estimated $61K sold.

Marshall Wace North America first reported a position in DTIL in Q1 2019 and held it in 4 quarters. The position peaked at $939K in Q1 2019. 109 funds tracked by Wall St. Rank hold DTIL as of Q1 2020.

  • Marshall Wace North America reported no remaining Precision BioSciences position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace North America sold 146 Precision BioSciences shares in Q1 2020, an estimated $61K.
  • Marshall Wace North America first reported a position in Precision BioSciences in Q1 2019 and held it in 4 quarters.
  • Marshall Wace North America's Precision BioSciences position peaked at $939K in Q1 2019.
  • 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2020.

Based on Marshall Wace North America's 13F filing for Q1 2020, filed 15 May 2020.